AMLX Company Profile and Key Details

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stock price is $3.62 in the last trading session. During the trading session, AMLX stock reached the peak price of $3.70 while $3.36 was the lowest point it dropped to. The percentage change in AMLX stock occurred in the recent session was 5.85% while the dollar amount for the price change in AMLX stock was $0.20.

The NASDAQ listed AMLX is part of Biotechnology industry that operates in the broader Healthcare sector. Amylyx Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Dr. Patrick D. Yeramian M.D., MBA, Ph.D.
Global Head of Clinical R&D and Chief Medical Officer
Mr. Justin B. Klee
Co-Founder, Co-Chief Executive Officer & Director
Mr. James M. Frates M.B.A.
Chief Financial Officer
Ms. Shauna Horvath
Head of Global Marketing
Mr. Joshua B. Cohen
Co-Founder, Co-Chief Executive Officer & Director
Ms. Gina M. Mazzariello
Chief Legal Officer & Gen. Counsel
Ms. Margaret M. Olinger M.B.A
Global Head of Commercial & Chief Commercial Officer
Ms. Debra L. Canner
Global Head of HR & CHRO
Mr. Chris Aiello
Head of Canada & GM
Lindsey Allen
Head of Investor Relations & Communications

AMLX's closing price is 129.84% higher than its 52-week low of $1.58 where as its distance from 52-week high of $19.95 is -81.85%.

Number of AMLX employees currently stands at 384.

Official Website of AMLX is: https://amylyx.com

AMLX could be contacted at phone 617 682 0917 and can also be accessed through its website. AMLX operates from 43 Thorndike Street, Cambridge, MA 02141, United States.

AMLX stock volume for the day was 1M shares. The average number of AMLX shares traded daily for last 3 months was 1.05M.

The market value of AMLX currently stands at $310.20M with its latest stock price at $3.62 and 85.69M of its shares outstanding.